Mizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks

February 4, 2025
Mizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocksMizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks
Share This

Jared Holz, Mizuho Securities America healthcare sector strategist, joins ‘Squawk Box’ to break down the quarterly earnings results of Merck and Pfizer, 2025 outlook for pharmaceutical stocks, and more.

Latest Mizuho News

The Energy Department's '$17 billion question' around nuclear energy

The Energy Department's '$17 billion question' around nuclear energy

June 29, 2026
Robinhood could be first ‘hyperscaler’ of online brokerages, says Mizuho’s Dan Dolev

Robinhood could be first ‘hyperscaler’ of online brokerages, says Mizuho’s Dan Dolev

July 2, 2026
Why SpaceX's future depends on Starship

Why SpaceX's future depends on Starship

July 20, 2026

Mizuho news from around the globe

back-to-top-blue